, India: Mint story on patent loophole in India regarding the importation of generics: (Spicy IP), India: WHO lambasts Indian drug regulatory system: (Spicy IP), India: Minister to ensure that reduced excise duty to reflect in drug prices: (Spicy IP), India: SCC journal article ‘Intellectual property rights and the challenges faced by the pharmaceutical industry’: (Spicy IP), Poland: Trade marks for medicines: (Class 46), US: IPO publishes letter… [read post]